
Purdue Pharma and Sackler Family Conclude Historic $7.4 Billion Opioid Settlement
In a landmark development regarding the ongoing opioid crisis in the United States, Purdue Pharma, the maker of the highly controversial painkiller OxyContin, along with the Sackler family, has agreed to a staggering $7.4 billion settlement. This settlement is aimed at resolving claims from thousands of individuals and municipalities affected by the opioid epidemic, further adding to the extensive legal battles the company has been embroiled in.
Continue reading
Canadian Supreme Court Greenlights Class Action Against Opioid Makers in British Columbia
In a landmark ruling, the Supreme Court of Canada has ruled that British Columbia can proceed with a class action lawsuit targeting opioid manufacturers. This groundbreaking decision, announced on November 29, 2024, comes amidst a national crisis concerning opioid-related overdoses and deaths that have plagued Canada for several years. The court's ruling signifies a pivotal moment in the fight against the opioid epidemic, allowing the province to hold pharmaceutical companies accountable for their alleged roles in fueling the crisis.
Continue reading